年轻及低手术风险患者EVAR的早远期结局:GREAT注册研究
基于GREAT全球注册研究3217例肾下腹主动脉瘤标准EVAR患者,比较年轻(<60岁)与老年、低风险(MPRS<3)与中高风险患者的结局。年轻本身不影响早期死亡和MAE,低风险患者早期死亡和MAE显著更低;5年总生存年轻和低风险均更高,低风险还降低主动脉相关死亡和再干预。低手术风险而非年轻本身预测优良结局。
要点
- 低手术风险(MPRS<3)而非年轻本身预测EVAR后优良的早期和5年结局。
- 年轻患者5年总生存更高(88% vs 76%),但早期死亡和MAE与老年无显著差异。
- 低风险患者5年主动脉相关死亡和再干预率显著低于中高风险患者。
核心结论
- 低手术风险而非年轻本身预测EVAR后优良的早期结局及低5年死亡率、主动脉相关死亡率和再干预率。
研究设计与样本
- GREAT全球注册研究回顾性分析3217例肾下腹主动脉瘤接受标准EVAR的患者。
- 排除既往AAA修复或同期手术者;年轻定义为<60岁,手术风险用MPRS评分分为低(<3)、中(3-11)、高(>11)风险。
主要发现
- 年轻患者近端瘤颈成角更小(27.2±18.4° vs 30.9±21.5°;p=0.05)。
- 低风险患者较中高风险者瘤颈更长(3±1.8 vs 2.8±1.4 cm;p=0.01)且成角更小(29.7±21.8° vs 33.2±22.2°;p=0.01)。
- 年轻与老年早期死亡率(0% vs 0.6%;p=0.62)和MAE(3.9% vs 6.1%;p=0.20)无显著差异。
- 低风险较中高风险早期死亡率(0.1% vs 0.7%;p=0.04)和MAE(4.1% vs 6.7%;p=0.005)显著更低。
- 5年总生存年轻更高(88% vs 76%;p<0.001),低风险更高(77% vs 54%;p<0.001);低风险主动脉相关死亡(0% vs 2%;p=0.04)和再干预率(6% vs 11%;p=0.007)显著更低。
关键数值与推荐
- 年轻定义:年龄<60岁;手术风险用MPRS评分:低风险<3,中风险3-11,高风险>11。
- MAE为30天主要不良事件;时间事件终点用Kaplan-Meier曲线计算。
临床怎么用
- 对年轻且低手术风险AAA患者,EVAR可获优良早期和5年结局,决策应综合手术风险而非仅凭年龄。
- 低风险患者5年主动脉相关死亡和再干预率低,支持在此类患者中优先考虑EVAR。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate early- and long-term outcomes of endovascular aneurysm repair (EVAR) for infrarenal abdominal aortic aneurysm (AAA) in young and low surgical risk patients. METHODS: The global registry for endovascular aortic treatment (GREAT) was queried for all patients with AAA undergoing standard EVAR; patients were excluded if had previous AAA repair or underwent concomitant procedures. Young patients were defined if age <60; surgical risk was assessed through the validated Medicare perioperative risk score (MPRS) based on age, sex, renal function, heart failure, and peripheral vascular disease. Patients were classified as low (MPRS<3), average (MPRS 3-11), or high (MPRS>11) risk. Young versus older patients and low-risk versus average/high-risk patients were compared. The primary endpoints were early (30 days) major adverse events (MAEs), 5-year freedom from overall mortality, aortic-related mortality, and freedom from device-related reinterventions. Time-to-event endpoints were calculated by Kaplan-Meier curves. RESULTS: Of 3217 included patients, 182 (6%) were <60 years old, 956 (30%) had a low surgical risk, 1561 (49%) an average risk, 700 (22%) a high risk. Young patients had a less angulated proximal neck (27.2±18.4° vs 30.9±21.5°; p=0.05); in low-risk compared to average/high-risk patients, a longer neck length (3±1.8 vs 2.8±1.4 cm; p=0.01) and lower neck angulation (29.7±21.8° vs 33.2±22.2°; p=0.01) were present. Young age alone had no significant impact on early mortality (0% vs 0.6%; p=0.62.) and MAEs (3.9% vs 6.1%; p=0.20), while these were significantly lower in low-risk compared to average/high-risk patients (early mortality: 0.1% vs 0.7%, p=0.04; MAEs: 4.1% vs 6.7%, p=0.005). At 5 years, overall survival was significantly higher in young (88% vs 76%; p<0.001) and lower-risk (77% vs 54%; p<0.001) patients; low-risk patients also had significantly decreased aortic-related mortality (0% vs 2%; p=0.04) and reintervention rates (6% vs 11%; p=0.007). There were no statistically significant differences in mortality (0% vs 2%; p=0.42) and reintervention rate (10% vs 10%; p=1.00) between young and older patients. CONCLUSION: In this real-world registry, EVAR was more often offered in cases with suitable anatomy in young and low-risk patients. Low operative risk, rather than young age alone, predicted excellent early outcomes and low 5-year mortality, aortic-related mortality, and reintervention rates.
引用
- Piazza M, Squizzato F, Suominen V, et al. Early and Long-Term Outcomes of Endovascular Aortic Repair in Young and Low Surgical Risk Patients in the Global Registry for Endovascular Aortic Treatment. J Endovasc Ther. 2021. PMID: 34510939. doi:10.1177/15266028211045703
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。